Blinding the monocytes to protect the heart.
作者信息
Charo Israel F
出版信息
Circulation. 2013 May 21;127(20):2006-8. doi: 10.1161/CIRCULATIONAHA.113.003045. Epub 2013 Apr 24.
Abstract
摘要
相似文献
1
Blinding the monocytes to protect the heart.使单核细胞失活以保护心脏。
Circulation. 2013 May 21;127(20):2006-8. doi: 10.1161/CIRCULATIONAHA.113.003045. Epub 2013 Apr 24.
2
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.单核细胞靶向 RNAi 靶向 CCR2 可改善动脉粥样硬化倾向小鼠的梗死愈合。
Circulation. 2013 May 21;127(20):2038-46. doi: 10.1161/CIRCULATIONAHA.112.000116. Epub 2013 Apr 24.
3
Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.具有siCCR2的光致发光介孔硅纳米颗粒改善急性心肌梗死后间充质基质细胞移植的效果。
Theranostics. 2015 Jun 25;5(10):1068-82. doi: 10.7150/thno.11517. eCollection 2015.
4
Therapeutic siRNA silencing in inflammatory monocytes in mice.在小鼠的炎症单核细胞中进行治疗性 siRNA 沉默。
Nat Biotechnol. 2011 Oct 9;29(11):1005-10. doi: 10.1038/nbt.1989.
5
Ly6C Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report.Ly6C单核细胞在稳态及心肌梗死后于心脏中呈振荡变化——简要报告
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1640-1645. doi: 10.1161/ATVBAHA.117.309259. Epub 2017 Jun 29.
6
Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.过氧化物酶体增殖物激活受体-γ 靶向纳米医学通过在临床前动物模型中改变单核细胞/巨噬细胞极化促进急性心肌梗死后的心脏愈合。
Cardiovasc Res. 2019 Feb 1;115(2):419-431. doi: 10.1093/cvr/cvy200.
7
Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells.心肌梗死激活CCR2(+)造血干细胞和祖细胞。
Cell Stem Cell. 2015 May 7;16(5):477-87. doi: 10.1016/j.stem.2015.04.008.
8
Murine macrophage chemokine receptor CCR2 plays a crucial role in macrophage recruitment and regulated inflammation in wound healing.鼠源巨噬细胞趋化因子受体 CCR2 在巨噬细胞募集和调控伤口愈合中的炎症反应中发挥着关键作用。
Eur J Immunol. 2018 Sep;48(9):1445-1455. doi: 10.1002/eji.201747400. Epub 2018 Jun 26.
9
CCR2 Contributes to F4/80+ Cells Migration Along Intramembranous Bone Healing in Maxilla, but Its Deficiency Does Not Critically Affect the Healing Outcome.CCR2 有助于 F4/80+ 细胞沿上颌骨膜内骨愈合的迁移，但它的缺乏并不严重影响愈合结果。
Front Immunol. 2018 Aug 10;9:1804. doi: 10.3389/fimmu.2018.01804. eCollection 2018.
10
Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.纳米颗粒包裹 Toll 样受体 4 抑制剂通过抑制单核细胞介导致炎减轻小鼠心肌缺血再灌注损伤。
Cardiovasc Res. 2019 Jun 1;115(7):1244-1255. doi: 10.1093/cvr/cvz066.
引用本文的文献
1
Xuezhitong capsule, an extract of , exhibits reverse cholesterol transport and accompanies high-density lipoprotein levels to protect against hyperlipidemia in ApoE mice.血脂通胶囊，一种……的提取物，具有逆向胆固醇转运作用，并伴随高密度脂蛋白水平升高，从而在载脂蛋白E小鼠中预防高脂血症。
你提供的原文中“an extract of ”后面内容缺失。
Ann Transl Med. 2019 Jun;7(11):239. doi: 10.21037/atm.2019.04.77.
2
Human Gingiva-Derived Mesenchymal Stem Cells Modulate Monocytes/Macrophages and Alleviate Atherosclerosis.人牙龈间充质干细胞调节单核细胞/巨噬细胞并减轻动脉粥样硬化。
Front Immunol. 2018 Apr 30;9:878. doi: 10.3389/fimmu.2018.00878. eCollection 2018.
3
Photoluminescent Mesoporous Silicon Nanoparticles with siCCR2 Improve the Effects of Mesenchymal Stromal Cell Transplantation after Acute Myocardial Infarction.具有siCCR2的光致发光介孔硅纳米颗粒改善急性心肌梗死后间充质基质细胞移植的效果。
Theranostics. 2015 Jun 25;5(10):1068-82. doi: 10.7150/thno.11517. eCollection 2015.
4
Interaction network analysis revealed biomarkers in myocardial infarction.相互作用网络分析揭示了心肌梗死中的生物标志物。
Mol Biol Rep. 2014 Aug;41(8):4997-5003. doi: 10.1007/s11033-014-3366-4. Epub 2014 Apr 20.
本文引用的文献
1
Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice.单核细胞靶向 RNAi 靶向 CCR2 可改善动脉粥样硬化倾向小鼠的梗死愈合。
Circulation. 2013 May 21;127(20):2038-46. doi: 10.1161/CIRCULATIONAHA.112.000116. Epub 2013 Apr 24.
2
Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal.Nr4a1 依赖性 Ly6C(low) 单核细胞监测内皮细胞并协调其清除。
Cell. 2013 Apr 11;153(2):362-75. doi: 10.1016/j.cell.2013.03.010.
3
Cholesterol efflux: a novel regulator of myelopoiesis and atherogenesis.胆固醇外排：一种新的造血调控因子和动脉粥样硬化形成的调节因子。
Arterioscler Thromb Vasc Biol. 2012 Nov;32(11):2547-52. doi: 10.1161/ATVBAHA.112.300134.
4
Molecular imaging in atherosclerosis: FDG PET.动脉粥样硬化的分子影像学：FDG PET。
Curr Atheroscler Rep. 2012 Oct;14(5):429-37. doi: 10.1007/s11883-012-0264-x.
5
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis.急性心肌梗死中单核细胞的快速动力学是由骨髓外单核细胞生成维持的。
J Exp Med. 2012 Jan 16;209(1):123-37. doi: 10.1084/jem.20111009. Epub 2012 Jan 2.
6
Therapeutic siRNA silencing in inflammatory monocytes in mice.在小鼠的炎症单核细胞中进行治疗性 siRNA 沉默。
Nat Biotechnol. 2011 Oct 9;29(11):1005-10. doi: 10.1038/nbt.1989.
7
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).白细胞介素-1β 抑制与复发性心血管事件的预防：卡那奴单抗抗炎血栓结局研究（CANTOS）的原理和设计。
Am Heart J. 2011 Oct;162(4):597-605. doi: 10.1016/j.ahj.2011.06.012. Epub 2011 Sep 14.
8
Monocyte and macrophage dynamics during atherogenesis.动脉粥样硬化形成过程中的单核细胞和巨噬细胞动力学。
Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1506-16. doi: 10.1161/ATVBAHA.110.221127.
9
Progress and challenges in translating the biology of atherosclerosis.动脉粥样硬化生物学翻译的进展与挑战。
Nature. 2011 May 19;473(7347):317-25. doi: 10.1038/nature10146.
10
Effect of CC chemokine receptor 2 CCR2 blockade on serum C-reactive protein in individuals at atherosclerotic risk and with a single nucleotide polymorphism of the monocyte chemoattractant protein-1 promoter region.CC 趋化因子受体 2（CCR2）阻断对动脉粥样硬化风险个体和单核细胞趋化蛋白-1 启动子区域单核苷酸多态性患者血清 C 反应蛋白的影响。
Am J Cardiol. 2011 Mar 15;107(6):906-11. doi: 10.1016/j.amjcard.2010.11.005. Epub 2011 Jan 19.
Zotero 插件